The Agilent Technologies-backed tissue analysis device maker has selected the Nasdaq Global Select Market for its initial public offering.

Access Biotechnology is among the initial investors disclosed by Eliem Therapeutics, which is targeting neuronal excitability disorders.

The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

The business service provider has added $40m to the round's Stripe-backed first close, doubling its valuation to $1.2bn in the process.

The truck management platform developer increased its overall funding to $31m in a series B round featuring Axa Venture Partners.

SoftBank-backed co-working space provider WeWork will finally get a public listing, at a $9bn initial enterprise value.

The Alphabet and Tencent-backed automation software producer, valued at $35bn as of last month, has filed for a $1bn offering.

The Lockheed Martin-backed satellite launch system developer has now raised at least $219m of funding ahead of its first official launch.

The Novo-backed musculoskeletal disease therapy developer floated in an upsized IPO before its share price almost doubled on its first day of trading.

Alphabet, Citi and Wells Fargo were among the investors in digital notary services provider Notarize, in a round valuing it at $760m.